Reilly Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 835 |
|
|
2021
Q3 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 748 |
|
|
2021
Q2 | $6K | Hold |
2,000
| – | – | ﹤0.01% | 767 |
|
|
2021
Q1 | $5K | Hold |
2,000
| – | – | ﹤0.01% | 792 |
|
|
2020
Q4 | $4K | Hold |
2,000
| – | – | ﹤0.01% | 730 |
|
|
2020
Q3 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 754 |
|
|
2020
Q2 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 817 |
|
|
2020
Q1 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 794 |
|
|
2019
Q4 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 811 |
|
|
2019
Q3 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 825 |
|
|
2019
Q2 | $2K | Hold |
2,000
| – | – | ﹤0.01% | 868 |
|
|
2019
Q1 | $3K | Hold |
2,000
| – | – | ﹤0.01% | 861 |
|
|
2018
Q4 | $2K | Sell |
2,000
-286
| -13% | -$286 | ﹤0.01% | 858 |
|
|
2018
Q3 | $5K | Hold |
2,286
| – | – | ﹤0.01% | 828 |
|
|
2018
Q2 | $4K | Hold |
2,286
| – | – | ﹤0.01% | 847 |
|
|
2018
Q1 | $5K | Hold |
2,286
| – | – | ﹤0.01% | 778 |
|
|
2017
Q4 | $4K | Hold |
2,286
| – | – | ﹤0.01% | 811 |
|
|
2017
Q3 | $6K | Buy |
+2,286
| New | +$6K | ﹤0.01% | 723 |
|